
FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C
According to a story from ir.stockpr.com, the biotechnology company CTD Holdings, Inc., recently announced that the US Food and Drug Administration (FDA) has issued an approval for an individual Investigational…